Equibles does not estimate personal net worth.
Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ABOS alertsMatt Zuga is recorded as CFO at Acumen Pharmaceuticals, Inc. (ABOS). Matt Zuga has spoken on 16 earnings calls across 1 company, most recently for Acumen Pharmaceuticals, Inc. on August 12, 2026. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Dr. George Golumbeski (Chairman and Board Member), Matthew Zuga (CFO) and 2 others.
“As a reminder, our second quarter 2026 financial results are available in the press release we issued this morning and in our 10-Q we will file later today.”
“As a reminder, our first quarter 2026 financial results are available in the press release we issued this morning and in our 10-Q we will file later today.”
“As a reminder, our full year 2025 financial results are available in the press release we issued this morning, and in our 10-K we will file later today.”
“As a reminder, our third quarter 2025 financial results are available in the press release we issued this morning and in our 10-Q we will file later today.”
“As a reminder, our second quarter 2025 financial results are available in the press release we issued this morning and in our 10-Q, which we will file later today.”
Biotechnology · Healthcare
CFO
